Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
British Journal of General Practice
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Letters

ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison

David Dunwell
British Journal of General Practice 2013; 63 (607): 73-74. DOI: https://doi.org/10.3399/bjgp13X663028
David Dunwell
Mayfly Cottage, Netton Island, Bishopstone, Salisbury, SP5 4DD. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DavidDunwell@btinternet.com
  • Article
  • Info
  • eLetters
  • PDF
Loading

In their Global Health editorial BJGP (October) on exotic infections, Behrens and Coltart did not mention the more mundane high prevalence of protozoal infections in warmer climates.1 We caught the anaerobic protozoa Blastocystis spp and Dientamoeba fragilis in Burma, however they are already common in UK, but little known to practitioners.

Blastocystis was the most common enteric parasite (6.9%) found in routine stool samples in a study in Wales2 and D. fragilis was found in up to 16.9% of samples submitted to alternative practitioners.3 However, the detection of both parasites is difficult and requires specialist laboratories; even then they may not be found. Faeco-oral seems their likely mode of transmission.

The pathogenic nature of D. fragilis is now more accepted,4 but two forms are known;5 while nine different subtypes of Blastocystis have been reported, observed disorders appear to be subtype dependent.6 Both protozoa have been linked to IBS.7,8

Treatment of Blastocystis is varied and metronidazole has shown resistance.9 For D. fragilis, only secnidazole10 and paromomycin11 gave very low treatment failure rates. Although both medicines are old, and both are registered and used within the EU, neither is registered for any use in UK.

My wife and I presented common severely debilitating symptoms of chronic fatigue and inability to concentrate for extended periods. I initially had severe diarrhoea, followed by soreness in the lower bowel, while my wife showed almost no intestinal disturbance or discomfort, however when we both had the same diet, the symptoms were the same. Later, headaches became more prevalent. The addition of milk (2% fat) plus cereals, particularly wheat based, increased the bowel disturbance. We had many blood and stool tests, with essentially no adverse findings. After many months and over 10 stool samples from each, I was diagnosed with D. fragilis and my wife with Blastocystis. Both had been found by microscopic examination of preserved stained specimens.

The parasites were treated: D. fragilis with paromomycin (750 mg tid) for 10 days (28 mg/kg) and Blastocystis with nitazoxanide (500 mg bid) for 3 days. Bowel disturbance continued for several weeks in both patients.

Our experiences, although limited, do offer direct comparisons between the parasites and support the conclusion that both can be pathogenic and the effects of both organisms can be similar, giving the ME (myalgic encephalopathy) symptoms of chronic physical and mental fatigue, with bowel disturbances related to cereal/milk diet. However, for patients and practitioners, the biggest problem is lack of efficacious approved drugs in UK.

I wish to thank the laboratory staff in the Department of Medical Parasitology at the London School of Hygiene and Tropical Medicine for making the diagnoses.

  • © British Journal of General Practice 2013

REFERENCES

  1. 1.↵
    1. Coltart CE,
    2. Behrens RH
    (2012) The new health threats of exotic and global travel. Br J Gen Pract 62(603):512–513.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Windsor JJ,
    2. Macfarlane L,
    3. Hughes-Thapa G,
    4. et al.
    (2002) Incidence of Blastocytis hominis in faecal samples submitted for routine microbiological analysis. Br J Biomed Sci 59(3):154–157.
    OpenUrlPubMed
  3. 3.↵
    1. Schuster H,
    2. Jackson RS
    (2009) Prevalence of Dientamoeba fragilis among patients consulting complementary medicine practitioners in the British Isles. J Clin Pathol 62(2):182–184.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Barratt JL,
    2. Harkness J,
    3. Marriott D,
    4. et al.
    (2011) A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2(1):3–12.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Johnson JA,
    2. Clark CG
    (2000) Cryptic genetic diversity in Dientamoeba fragilis. J Clin Microbiol 38(12):4653–4654.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Tan KSW,
    2. Mirza H,
    3. Teo JDW,
    4. et al.
    (2010) Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep 12(1):28–35.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Borody T,
    2. Warren E,
    3. Wettstein A,
    4. et al.
    (2002) Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 17(Suppl):A103.
    OpenUrlCrossRef
  8. 8.↵
    1. Jimenez-Gonzalez DE,
    2. Martinez-Flores WA,
    3. Reyes-Gordillo J,
    4. et al.
    (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110(3):1269–1275.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Haresh K,
    2. Suresh K,
    3. Khairul Anus A,
    4. Saminathan S
    (1999) Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 4(4):274–277.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Girginkarde şler N,
    2. Coşkun S,
    3. Cüneyt Balcioşlu I,
    4. et al.
    (2003) Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect 9(2):110–113.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. van Hellemond JJ
    Superior efficacy of paromomycin for eradication of Dientamoeba fragilis in adults. Abstract 335. 22nd European Congress of Clinical Microbiology and Infectious Diseases, 31 March – 3 April 2012, London.
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 63 (607)
British Journal of General Practice
Vol. 63, Issue 607
February 2013
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison
David Dunwell
British Journal of General Practice 2013; 63 (607): 73-74. DOI: 10.3399/bjgp13X663028

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison
David Dunwell
British Journal of General Practice 2013; 63 (607): 73-74. DOI: 10.3399/bjgp13X663028
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • An earlier diagnosis of heart failure
  • Group A strep: has point-of-care testing for primary care finally come of age?
  • Author response
Show more Letters

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242